Tris(pentafluorophenyl)phosphine, commonly abbreviated as P(C6F5)3, is a highly electron-withdrawing phosphine ligand. It is a versatile compound used extensively in organometallic chemistry and catalysis. The compound is typically synthesized via the reaction of pentafluorophenyl lithium with phosphorus trichloride. P(C6F5)3 has gained significant attention for its ability to stabilize low-coordinate metal complexes, particularly those in low oxidation states. Its strong electron-withdrawing properties and steric bulk contribute to the stability and reactivity of these complexes. P(C6F5)3 has found applications in various catalytic reactions, including cross-coupling reactions, hydrogenation reactions, and polymerization reactions. Due to its unique electronic and steric properties, P(C6F5)3 has played a crucial role in advancing the understanding of organometallic chemistry and catalysis.'
```
ID Source | ID |
---|---|
PubMed CID | 102076 |
SCHEMBL ID | 168040 |
MeSH ID | M0173711 |
Synonym |
---|
tris(pentafluorophenyl)phosphine, 97% |
tris(pentafluorophenyl)phosphine |
1259-35-4 |
tris(perfluorophenyl)phosphine |
T2484 |
FT-0652908 |
tris(2,3,4,5,6-pentafluorophenyl)phosphane |
A805443 |
einecs 215-021-2 |
r4p6l83yfz , |
phosphine, tris(pentafluorophenyl)- |
unii-r4p6l83yfz |
tris(2,3,4,5,6-pentafluorophenyl)phosphine |
SC11111 |
tris(pentafluorophenyl)phosphine;tris(perfluorophenyl)phosphine |
AKOS015853251 |
SCHEMBL168040 |
mlo 74-62 |
FQLSDFNKTNBQLC-UHFFFAOYSA-N |
tris(2,3,4,5,6-pentafluorophenyl)phosphine # |
DTXSID70154988 |
J-005302 |
mfcd00079654 |
c18f15p |
AS-66527 |
D70445 |
SY009849 |
tris-pentafluorophenyl-phosphane |
BCP22560 |
phosphine, tris(2,3,4,5,6-pentafluorophenyl)- |
CS-W009612 |
HY-W008896 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.40) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |